At the conclusion of this activity, learners should be able to:

• Review addiction identification and evidence-based treatments.
• Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
• Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
• Explain the process of buprenorphine induction as well as stabilization and maintenance.
• Discuss other approved antagonist and agonist medications to treat OUD.
• Discuss basic office protocols including medical record documentation and confidentially.
• Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD. 

Fee: No cost 

To be awarded a maximum of 8 AMA PRA Category 1 Credits™ or 8 AAPA Category 1 CME credits you must:

• Review 8 training modules (8 hours) provided in this activity.
• Complete a final evaluation and follow instructions at the end of the course regarding how to retrieve your certificate*.

*Credit will not be awarded unless all components of the program are completed. Partial credit will not be awarded.